Posted by Michael Wonder on 25 Aug 2025
European Commission approves tablet formulation of BeOne Medicines’ Brukinsa for all approved indications
21 August 2025 - Tablets will advance treatment simplicity and convenience to meet patient needs across Europe.
BeOne Medicines today announced that the European Commission has approved a new film coated tablet formulation of Brukinsa (zanubrutinib) for all approved indications.
